Association between clinical and laboratory factors and response to sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes: a retrospective observational study.
Sofia PitsiavaGeorgios DimakopoulosVasilis TsimihodimosKalliopi KotsaTheocharis KoufakisPublished in: Expert opinion on pharmacotherapy (2024)
Our findings suggest that specific clinical and laboratory parameters are associated with response to SGLT2i treatment and can contribute to a more personalized approach to T2D care.